Product Development for Vaccines Advisory Committee
PDVAC is an independent standing WHO committee of experts which provides external advice to WHO related to priority infectious disease pathogens, associated vaccine and monoclonal antibody product development approaches and related manufacturing and delivery technologies.
Product Development for Vaccine Advisory Committee
Photographer Asem Ansari, photograph courtesy of icddr,b through Alejandro Cravioto
©
Credits
Established in 2014, the Product Development for Vaccines Advisory Committee (PDVAC) is an independent, standing committee of experts which provides external advice to WHO related to vaccine and monoclonal antibody candidates for priority infectious disease pathogens, generally at the stage of early clinical development. The committee’s remit covers disease areas where there is, or may be, substantial disease burden in low and middle income countries (LMICs), where there is product development activity which may benefit from WHO guidance, or where novel platform technologies could expedite availability and access of vaccine products in LMICs.